专利号:US-7273932-B1 优先权日:1999-05-28 标题 :Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use 发明人:LABARBERA ANDREW R; WANG YIFANG; ZHU CHANGHONG 权利人:UNIV CINCINNATI 摘要:The invention relates to antisense oligonucleotides, in particular to antisense oligonucleotides to receptor genes, and the use of such oligonucleotides to regulate reproductive function and as chemopreventive or as a chemotherapeutic for various cancers, especially ovarian cancers. The invention also provides a method for preventing estrogen synthesis, a function of developing ovarian follicles, a therapeutic consideration for the prevention and treatment of some cancers of the breast, endometrium, ovary and cervix and of some endometriosis. The invention also relates to pharmaceutical compositions containing antisense oligonucleotides (ODNs, having 8 to 60 nucleotides) that act by binding to intracellular molecular targets. Optionally, for efficient delivery to a target DNA, RNA or protein, the ODNs may be covalently linked to a carrier moiety, which facilitates delivery of the ODN to the cytosol.
1: Rezvanpour A, Don-Wauchope AC. Clinical implications of estrone sulfate measurement in laboratory medicine. Crit Rev Clin Lab Sci. 2017 Mar;54(2):73-86. doi: 10.1080/10408363.2016.1252310. Epub 2016 Dec 14. 105:50-8. doi: 10.1016/j.steroids.2015.11.009. Epub 2015 Dec 5. 99(4):1393-9. doi: 10.1210/jc.2013-2607. Epub 2014 Jan 16. 60(3):299-306. doi: 10.1016/0039-128x(94)00048-h. 112(7):1088-93. doi: 10.1016/j.jand.2012.02.005. Epub 2012 May 5.
合成参考文献
参考文献:10.1126/science.1174621 摘要:Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 01;327(5961):46–50. doi: 10.1126/science.1174621.